The above chart presents the market trend analysis for midas pharma gmbh from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 7 transactions, with a transaction quantity of 4006 and a transaction weight of 0.
Product description
F O C ASPIRIN N ACETYLSALICYLIC ACID 100MG TABLETS 98XFOR TESTING PURPOSE ONLY F O C ASPIRIN N ACETYLSALICYLIC ACID 100MG TABLETS 98X
Expand
Product description
F O C SORTIS ATORVASTATIN 40MG FILM COATED TABLETS 100X FOR TESTING PURPOSE ONLY F O C SORTIS ATORVASTATIN 40MG FILM COATED TABLETS 100
Expand
midas pharma gmbh is germany Buyer&Supplier,
and primarily engages in the import and export business of products such as spironolactone,cas no,ice.
According to the 52wmb.com global trade database, as of 2026-02-27, the company has completed 661 international trades,
with its main trading regions covering turkey,india,united states etc.
The core products include HS29322090,HS30049099,HS300490000000 etc,
often transported via bremerhaven,port hamburg, port frankfurt am main etc,
and its main trading partners are onko ilaç sanayi veticaret a.ş.,intas pharmaceuticals ltd.,pharmactive il.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on midas pharma gmbh is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.